MedTrace Logo

A Multi-omics Study of Epithelial Ovarian Cancer

NCT03742856 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 80

Last updated 2018-11-15

No results posted yet for this study

Summary

This study aims to analyze the multi-omics results between epithelial ovarian cancer (EOC) patient with different FIGO stages and pathological subtypes. The multi-omics profiles include whole exome sequencing, analysis of transcriptomics and metabolomics. A comprehensive multi-omics will reveal the invasiveness and tumorigenesis of EOC.

Conditions

  • Epithelial Ovarian Cancer
  • Tumor Invasiveness
  • Whole Exome Sequencing
  • Transcriptomics
  • Metabolomics
  • Tumorigenesis

Interventions

COMBINATION_PRODUCT

A multi-omics analysis

A multi-omics analysis including whole exome sequencing, transcriptomics and metabolomics.

Sponsors & Collaborators

  • Lei Li

    lead OTHER

Principal Investigators

  • Lei Li, M.D. · Peking Union Medical College Hospital

Eligibility

Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-11-10
Primary Completion
2020-11-23
Completion
2020-11-23

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03742856 on ClinicalTrials.gov